This page is for informational and educational purposes only. This is not medical advice. Do not use any compound without consulting a qualified healthcare professional.

Tirzepatide

Also known as: Mounjaro, Zepbound

Fat Loss / GLP-1Grey areaHalf-life: 5d

Overview

Tirzepatide is a dual GLP-1 and GIP receptor agonist approved for type 2 diabetes and obesity management. It has demonstrated average weight loss of 20-22% body weight in clinical trials, making it one of the most effective pharmacological weight loss agents available.

How it works

Activates both GLP-1 and GIP receptors. GLP-1 agonism suppresses appetite, slows gastric emptying, and improves insulin sensitivity. GIP agonism further enhances insulin secretion and may improve fat metabolism. The dual mechanism produces additive effects on weight loss and glycaemic control.

Primary uses

  • Fat loss
  • Type 2 diabetes
  • Appetite suppression
  • Blood sugar regulation
  • Cardiovascular health

What to expect

Based on reported user experiences and available research, here is a general timeline of effects:

  1. Days 1–14

    • Appetite reduction is typically noticeable within the first week
    • GIP and GLP-1 receptor activation begins immediately — digestive adaptation expected

  2. Days 14–56

    • Weight loss of 1-2% body weight is typical by week 4
    • Blood sugar improvements are measurable in this window
    • Energy and metabolic rate often improve as fat loss progresses

  3. Days 56–112

    • Clinical trials show average 15-20% body weight loss at 3-6 months
    • Cardiovascular risk markers are improving with sustained use
    • Insulin sensitivity is significantly improved by this stage

  4. Days 112–999

    • You are achieving outcomes comparable to clinical trial participants
    • Maintenance dose consideration is appropriate at this stage
    • Long-term cardiovascular and metabolic protection is well established

Storage and preparation

Store at 2-8°C refrigerated. Do not freeze. Keep away from light. Stable at room temperature for up to 21 days if needed during travel.

Available as a pre-filled pen — no reconstitution required. Research vials: reconstitute with bacteriostatic water, 1ml per 5mg vial gives 5mg/ml.

Research

The following studies are available via PubMed:

fat lossglp-1gipweight lossweekly injectionprescriptiondual agonist

Track your compound stack in Lymity

Log doses, track cycles, and see your timeline benefits in the app

Get early access